Daclizumab Subcutaneous and Fluoxetine Capsules and Tablets (PMDD)
Determining the interaction of Daclizumab Subcutaneous and Fluoxetine Capsules and Tablets (PMDD) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: fluoxetine
Brand name: Prozac, Prozac Weekly, PROzac Pulvules, Sarafem, Rapiflux, Selfemra
Synonyms: Fluoxetine, FLUoxetine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Fluoxetine Delayed-Release Capsules
- Daclizumab Subcutaneous-Fluoxetine Hydrochloride
- Daclizumab Subcutaneous-Fluoxetine Solution
- Daclizumab Subcutaneous-Fluoxiv Cream
- Daclizumab Subcutaneous-Fluoxymesterone
- Daclizumab Subcutaneous-Fluphenazine
- Fluoxetine Capsules and Tablets (PMDD)-Dacogen
- Fluoxetine Capsules and Tablets (PMDD)-Dacomitinib
- Fluoxetine Capsules and Tablets (PMDD)-Dactinomycin
- Fluoxetine Capsules and Tablets (PMDD)-Dactinomycin Injection
- Fluoxetine Capsules and Tablets (PMDD)-Dactinomycin Intravenous
- Fluoxetine Capsules and Tablets (PMDD)-Daklinza